Xcel Wealth Management, LLC Abb Vie Inc. Transaction History

Xcel Wealth Management, LLC

$338 Million
Q3 2024

A detailed history of Xcel Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Xcel Wealth Management, LLC holds 2,801 shares of ABBV stock, worth $512,807. This represents 0.16% of its overall portfolio holdings.

Number of Shares

2,801

Previous 2,801 -0.0%

Holding current value

$512,807

Previous $480,000 15.21%

% of portfolio

0.16%

Previous 0.15%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $8,513 - $9,941	-55 Reduced 1.93%	2,801 $480,000
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $3,516 - $4,006	22 Added 0.78%	2,856 $520,000
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $34,400 - $38,742	-250 Reduced 8.11%	2,834 $439,000
Q3 2023 Oct 17, 2023	SELL	$133.59 - $154.65 $1.55 Million - $1.79 Million	-11,580 Reduced 78.97%	3,084 $459,000
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $120,716 - $150,223	-911 Reduced 5.85%	14,664 $1.98 Million
Q1 2023 Apr 25, 2023	BUY	$144.61 - $166.54 $19,956 - $22,982	138 Added 0.89%	15,575 $2.48 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $15,075 - $18,079	-109 Reduced 0.7%	15,437 $2.5 Million
Q3 2022 Oct 20, 2022	BUY	$134.21 - $153.93 $671 - $769	5 Added 0.03%	15,546 $2.09 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $1.32 Million - $1.68 Million	-9,576 Reduced 38.13%	15,541 $2.38 Million
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $5.64 Million - $7 Million	-42,753 Reduced 62.99%	25,117 $4.07 Million
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $14,932 - $18,894	-139 Reduced 0.2%	67,870 $9.19 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $970,155 - $1.1 Million	9,118 Added 15.48%	68,009 $7.34 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $187,799 - $209,219	1,785 Added 3.13%	58,891 $6.63 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $653,594 - $719,529	6,389 Added 12.6%	57,106 $6.18 Million
Q4 2020 Jan 13, 2021	BUY	$80.49 - $108.67 $453,239 - $611,920	5,631 Added 12.49%	50,717 $5.43 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $687,280 - $806,640	8,000 Added 21.57%	45,086 $3.95 Million
Q2 2020 Jul 10, 2020	BUY	$73.37 - $98.18 $147,106 - $196,850	2,005 Added 5.72%	37,086 $3.64 Million
Q1 2020 Apr 07, 2020	BUY	$64.5 - $97.79 $141,900 - $215,138	2,200 Added 6.69%	35,081 $2.67 Million
Q4 2019 Jan 09, 2020	BUY	$72.13 - $90.25 $63,546 - $79,510	881 Added 2.75%	32,881 $2.91 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $514,861 - $619,011	8,175 Added 34.31%	32,000 $2.42 Million
Q2 2019 Nov 12, 2019	BUY	$65.7 - $83.98 $827,820 - $1.06 Million	12,600 Added 112.25%	23,825 $1.73 Million
Q1 2019 Nov 12, 2019	BUY	$77.14 - $90.79 $654,918 - $770,807	8,490 Added 310.42%	11,225 $904,000
Q4 2018 Nov 12, 2019	BUY	$77.85 - $96.01 $212,919 - $262,587	2,735 New	2,735 $252,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xcel Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xcel Wealth Management, LLC with notifications on news.

Account

Xcel Wealth Management, LLC Abb Vie Inc. Transaction History